FibroBiologics, Inc.
FBLG
$0.26
-$0.02-5.68%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/18/2026
-
Globe Newswire
3/12/2026
-
TipRanks Financial Blog
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
3/12/2026
-
Globe Newswire
3/8/2026
-
Ticker Report
3/6/2026
-
TipRanks Financial Blog
3/6/2026
-
MarketBeat
3/5/2026
-
The Fly
3/5/2026
-
The Fly
3/5/2026
-
Globe Newswire
3/4/2026
-
MarketBeat
3/3/2026
-
PR Newswire
3/3/2026
-
CNW Group - News Releases
3/3/2026
-
MarketBeat
3/2/2026
-
Ticker Report
3/2/2026
-
TipRanks Financial Blog
3/2/2026
-
Globe Newswire
2/26/2026
-
Globe Newswire
2/26/2026
-
Ticker Report
2/24/2026
-
Globe Newswire
2/24/2026
-
Ticker Report
2/23/2026
-
TipRanks Financial Blog
2/23/2026
-
Seeking Alpha - Healthcare
2/23/2026
-
SeekingAlpha.com: All News
2/23/2026
-
The Fly
2/23/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 24, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
End of March (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
281 671 5150
Address
455 East Medical Center Boulevard
Houston, TX 77598
Houston, TX 77598
Country
Year Founded
Business Description
Sector
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The...
more